The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune checkpoint inhibitor (ICI) toxicity in a large prospective cohort of patients with solid tumors: The I-CHECKIT study (SWOG S2013).
 
Krishna Gunturu
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb Foundation; Daiichi Sankyo/Lilly; Merck
 
Joseph Unger
Consulting or Advisory Role - AstraZeneca; Loxo/Lilly
Research Funding - Arnold Ventures
 
Dawn Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Amy Darke
No Relationships to Disclose
 
Alexander Wei
Honoraria - Telix Pharmaceuticals
Consulting or Advisory Role - Lilly
Speakers' Bureau - Merck
Research Funding - IDEAYA Biosciences (Inst); Novartis (Inst); Regeneron (Inst)
 
Siwen Hu-Lieskovan
Consulting or Advisory Role - Amgen; Cardinal Health; Delcath Systems; Immunocore; Replimune
 
Mark Walshauser
No Relationships to Disclose
 
Matthew Sochat
No Relationships to Disclose
 
Michael Fisch
Employment - Carelon Medical Benefits Management
Stock and Other Ownership Interests - Anthem
 
Norah Henry
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech; Novartis
Patents, Royalties, Other Intellectual Property - Royalty from Up-to-Date